Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaste changes on semaglutide are genuinely common. Many people on Wegovy notice that food tastes different, less appealing, or sometimes metallic — particularly in the first weeks of treatment or after a dose increase. This happens because semaglutide affects appetite-regulating pathways that also influence how the brain processes flavour and food reward, not just how hungry you feel. It is a recognised side effect, not a sign anything has gone wrong. These changes typically ease as your body adjusts, though for some people they persist at a lower intensity throughout treatment. Wegovy is a prescription-only medicine; whether it is clinically appropriate for you is a decision made with a qualified prescriber, not something that can be determined from a search alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes. The NHS lists taste disturbance among the recognised side effects of semaglutide, and clinicians who prescribe it routinely hear patients describe food tasting metallic, blander than usual, or simply less enjoyable than before. Some people find previously favourite foods suddenly off-putting. This is reported across both the injection form (Wegovy) and the wider semaglutide clinical programme.
The mechanism is not fully pinned down, but it likely involves two overlapping processes. First, GLP-1 receptors are present in the brain's reward circuitry (areas that govern how much pleasure you derive from eating) and activating them changes how food is processed, not just how much of it you want. Second, the slowing of gastric emptying that comes with semaglutide alters how taste compounds interact with receptors in the mouth and gut. For a fuller picture of how the medicine works at a system level, the semaglutide overview on our site covers the mechanisms in more detail.
Taste changes are most common early in treatment and after each dose increase. The NHS's guidance on semaglutide notes that gastrointestinal and related side effects (the category taste changes fall into) are typically mild to moderate and tend to improve over time. That said, for a minority of people the alteration in food perception does persist. It does not indicate harm; it is a reflection of how effectively the medicine is influencing appetite regulation.
The pattern varies between people, but some themes crop up repeatedly. Sweet foods are frequently described as cloying or too rich, which is why people who previously enjoyed chocolate or pastries may find them unappealing early in treatment. Fatty or very strongly flavoured foods often follow a similar pattern. A metallic or sour background taste is also reported, and this can make plain water taste slightly off, which in turn risks people drinking less than they should.
Meat (particularly red meat) is another commonly mentioned example. Some people find the smell as much as the taste changes, which is worth knowing because the aversion can lead to skipping protein-rich meals at exactly the point when adequate protein matters most. If altered taste is making it harder to eat a balanced diet, focusing on easily tolerated protein sources (eggs, fish, dairy, legumes) rather than trying to push through foods that have become unpleasant is a more practical approach.
If you are curious whether what you are experiencing lines up with what other Wegovy users notice, the question of whether Wegovy changes your taste is covered in more depth separately. And if the changes feel more structural (affecting your sense of flavour broadly rather than particular foods) there is a dedicated page on whether Wegovy can change your taste buds.
A metallic taste on Wegovy is disconcerting, but it is not a red flag on its own. It appears in self-reported data from clinical trials and in post-marketing reports, and it typically correlates with the early stages of treatment or the adjustment period after a dose step-up. Clinically, it is thought to relate to the same central and peripheral GLP-1 receptor activity described above.
Where you should seek prompt medical attention is if taste changes arrive alongside other symptoms: severe or persistent nausea, vomiting that prevents keeping fluids down, or significant abdominal pain. Pancreatitis is a known but infrequent serious side effect of GLP-1 medicines, and the MHRA's Drug Safety Update communications are clear that severe stomach pain reaching through to the back warrants urgent assessment. A metallic taste alone, with no accompanying pain or systemic symptoms, does not fit that picture.
If you have any doubt, the right call is always to contact your prescriber or call NHS 111 rather than wait. You can also report any suspected side effects through the MHRA Yellow Card scheme, which helps regulators monitor real-world experience with medicines like Wegovy.
The most effective practical step is patience alongside a few small adjustments. Serving food slightly cooler than usual can reduce the intensity of strong aromas that now feel off-putting. Mild seasoning with lemon, herbs or vinegar often cuts through the metallic background better than salt or sugar, which may already taste exaggerated. Keeping a drink nearby (water with a slice of cucumber or mint rather than plain water if the taste of plain water has shifted) helps maintain hydration without the aversion some people feel.
Meal timing matters too. Because gastric emptying is slower, eating smaller amounts more frequently is easier on both appetite and taste tolerance. Keeping your injection routine consistent is also part of the picture: a pen that lives in the fridge door (taken out for a few minutes before use so it is not ice-cold) is less likely to cause discomfort at the injection site, which in turn means the experience of taking the medicine feels less aversive overall.
If altered taste is affecting how you think about food and eating in a way that feels disordered or distressing, it is worth raising with your prescriber. The Wegovy treatment page covers when to consider reviewing your dose or approach. Separately, some patients find that other unexpected physical changes accompany treatment; changes to facial appearance on semaglutide is one topic our clinical team is regularly asked about, and it is covered factually there.
For anything else about how Wegovy fits into your wider health picture, including a guide to whether you can take doxycycline alongside Wegovy if you have been prescribed antibiotics at the same time, our frequently asked questions page is a good starting point, and our prescribers are available seven days a week for aftercare queries. If taste changes or any other side effects are making you reconsider whether treatment is right for you, checking your eligibility for a fresh clinical consultation is the sensible next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.